Nerandomilast
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Nerandomilast
- DrugBank Accession Number
- DB18237
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 448.97
Monoisotopic: 448.1448229 - Chemical Formula
- C20H25ClN6O2S
- Synonyms
- BI-1015550
- External IDs
- BI 1015550
- BI-1015550
- BI1015550
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- I5DGT51IB8
- CAS number
- 1423719-30-5
- InChI Key
- UHYCLWAANUGUMN-SSEXGKCCSA-N
- InChI
- InChI=1S/C20H25ClN6O2S/c21-14-10-22-17(23-11-14)13-2-7-27(8-3-13)19-24-15-4-9-30(29)16(15)18(25-19)26-20(12-28)5-1-6-20/h10-11,13,28H,1-9,12H2,(H,24,25,26)/t30-/m1/s1
- IUPAC Name
- (5R)-2-[4-(5-chloropyrimidin-2-yl)piperidin-1-yl]-4-{[1-(hydroxymethyl)cyclobutyl]amino}-5H,6H,7H-thieno[3,2-d]pyrimidin-5-ium-5-olate
- SMILES
- OCC1(CCC1)NC1=NC(=NC2=C1[S@+]([O-])CC2)N1CCC(CC1)C1=NC=C(Cl)C=N1
References
- General References
- Not Available
- External Links
- ChemSpider
- 129160248
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Not Yet Recruiting Treatment Idiopathic Pulmonary Fibrosis (IPF) / Progressive Pulmonary Fibrosis 1 2 Completed Treatment Idiopathic Pulmonary Fibrosis (IPF) 1 2 Not Yet Recruiting Treatment Idiopathic Pulmonary Fibrosis (IPF) 1 2 Not Yet Recruiting Treatment Interstitial Lung Disease Due to Systemic Disease / Scleroderma 1 1 Completed Treatment Healthy Volunteers (HV) 13
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 1.38 Chemaxon pKa (Strongest Acidic) 14.49 Chemaxon pKa (Strongest Basic) 3.4 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 8 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 104.13 Å2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 120.55 m3·mol-1 Chemaxon Polarizability 47.14 Å3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 14, 2023 21:43 / Updated at February 05, 2024 00:29